Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bruno Pietro Imbimbo, Stefania Ippati & Mark Watling. (2020) Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?. Expert Opinion on Drug Discovery 15:11, pages 1241-1251.
Read now
Read now
Bruno P. Imbimbo, Madia Lozupone, Mark Watling & Francesco Panza. (2020) Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives. Expert Opinion on Investigational Drugs 29:9, pages 919-933.
Read now
Read now
Ramón Cacabelos. (2020) How plausible is an Alzheimer’s disease vaccine?. Expert Opinion on Drug Discovery 15:1, pages 1-6.
Read now
Read now
Articles from other publishers (45)
Adekunle Aina, Shawn C. C. Hsueh, Ebrima Gibbs, Xubiao Peng, Neil R. Cashman & Steven S. Plotkin. (2023) De Novo Design of a β-Helix Tau Protein Scaffold: An Oligomer-Selective Vaccine Immunogen Candidate for Alzheimer’s Disease. ACS Chemical Neuroscience 14:15, pages 2603-2617.
Crossref
Crossref
Xiaokun Chen, Shenzhong Jiang, Renzhi Wang, Xinjie Bao & Yongning Li. (2023) Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects. Journal of Alzheimer's Disease 94:s1, pages S173-S186.
Crossref
Crossref
Michele Cerasuolo, Michele Papa, Anna Maria Colangelo & Maria Rosaria Rizzo. (2023) Alzheimer’s Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity. Biomedicines 11:3, pages 861.
Crossref
Crossref
Michele Tonelli, Marco Catto, Raimon Sabaté, Valeria Francesconi, Erik Laurini, Sabrina Pricl, Leonardo Pisani, Daniela Valeria Miniero, Grazia Maria Liuzzi, Elena Gatta, Annalisa Relini, Rosalina Gavín, Jose Antonio Del Rio, Fabio Sparatore & Angelo Carotti. (2023) Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease. European Journal of Medicinal Chemistry 250, pages 115169.
Crossref
Crossref
Zhenqi Yang, Yong Zou & Lifeng Wang. (2023) Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences 24:4, pages 3841.
Crossref
Crossref
Julian Szymański, Dominik Szwajgier & Ewa Baranowska-Wójcik. (2023) The Role of Beetroot Ingredients in the Prevention of Alzheimer’s Disease. Applied Sciences 13:2, pages 1044.
Crossref
Crossref
Zhipei Sang & Ling Huang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
405
473
.
Chen Meimei, Wang Fengzhen, Lei Huangwei, Li Candong & Yang Zhaoyang. (2022) Discovery of Taxus chinensis fruit wine as potentially functional food against Alzheimer's disease by UHPLC‐QE‐MS/MS, network pharmacology and molecular docking. Journal of Food Biochemistry 46:12.
Crossref
Crossref
Yanyan Cao & Run Zhang. (2022) The application of nanotechnology in treatment of Alzheimer’s disease. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yi Wang, Kaiyue Wang, Junyuan Yan, Qian Zhou & Xiaoying Wang. (2022) Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer’s Disease: Dietary Plant Polyphenols. International Journal of Molecular Sciences 23:22, pages 13886.
Crossref
Crossref
Daniel B. Hier, Sima Azizi, Matthew S. Thimgan & Donald C. WunschIIII. (2022) Tau kinetics in Alzheimer's disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Anuja Sharma, Jaspreet Singh Anand & Yatender Kumar. (2022) Immunotherapeutics for AD: A Work in Progress. CNS & Neurological Disorders - Drug Targets 21:9, pages 752-765.
Crossref
Crossref
José Martínez-Hernández, Julie Parato, Aditi Sharma, Jean-Marc Soleilhac, Xiaoyi Qu, Ellen Tein, Andrew Sproul, Annie Andrieux, Yves Goldberg, Marie-Jo Moutin, Francesca Bartolini & Leticia Peris. (2022) Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer’s disease. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Li Sun, Quanqian Peng, Chen Qian & Jiyun Li. (2022) Tau Content Prediction Based on Brain Network MLP-att Model. Tau Content Prediction Based on Brain Network MLP-att Model.
Hitesh Chopra, Shabana Bibi, Inderbir Singh, Mohammad Amjad Kamal, Fahadul Islam, Fahad A. Alhumaydhi, Talha Bin Emran & Simona Cavalu. (2022) Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Sara Mahdiabadi, Sara Momtazmanesh, George Perry & Nima Rezaei. (2022) Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review. Reviews in the Neurosciences 33:4, pages 365-381.
Crossref
Crossref
Mingchao Shi, Fengna Chu, Xiaoping Tian, Qiaolifan Aerqin, Feiqi Zhu & Jie Zhu. (2021) Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?. The Neuroscientist 28:3, pages 254-270.
Crossref
Crossref
Yi Yang, Limei Wang, Caijun Zhang, Yuqian Guo, Jintao Li, Chao Wu, Jianlin Jiao & Hong Zheng. (2022) Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK‐3β/β‐catenin signaling pathway. Chemical Biology & Drug Design 99:6, pages 884-896.
Crossref
Crossref
Pieter Dujardin, Roosmarijn E. Vandenbroucke & Lien Van Hoecke. (2022) Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease. Drug Discovery Today 27:5, pages 1261-1283.
Crossref
Crossref
Bruno P. Imbimbo, Stefania Ippati, Mark Watling & Claudia Balducci. (2021) A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies. Alzheimer's & Dementia 18:5, pages 1008-1037.
Crossref
Crossref
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. (2022) Personalized Management and Treatment of Alzheimer’s Disease. Life 12:3, pages 460.
Crossref
Crossref
Antoine Leuzy, Ruben Smith, Nicholas C. Cullen, Olof Strandberg, Jacob W. Vogel, Alexa Pichet Binette, Edilio Borroni, Shorena Janelidze, Tomas Ohlsson, Jonas Jögi, Rik Ossenkoppele, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Gregory Klein, Erik Stomrud & Oskar Hansson. (2022) Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. JAMA Neurology 79:2, pages 149.
Crossref
Crossref
Julia Doroszkiewicz, Piotr Mroczko & Agnieszka Kulczyńska-Przybik. (2022) Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis
of Alzheimer's Disease. Current Alzheimer Research 19:1, pages 16-31.
Crossref
Crossref
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
275
387
.
Makbule Dilara ODABAŞI & Zekiye Tuba TÜYLÜ KÜÇÜKKILINÇ. (2021) Alzheimer Hastalığı Tedavisindeki Güncel Yaklaşımlar. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Vyronia Vassilakopoulou, Chrysoula-Evangelia Karachaliou, Alexandra Evangelou, Christos Zikos & Evangelia Livaniou. (2021) Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives. Vaccines 9:11, pages 1278.
Crossref
Crossref
Santosh R. D’MelloIIIIII. (2021) MECP2 and the biology of MECP2 duplication syndrome. Journal of Neurochemistry 159:1, pages 29-60.
Crossref
Crossref
Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn & Adrian Israelson. (2021) All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration. Cells 10:9, pages 2438.
Crossref
Crossref
Katarzyna Potyrak, Benita Wiatrak, Edward Krzyżak, Łukasz Szczukowski, Piotr Świątek & Adam Szeląg. (2021) Effect of pyrrolo[3,4-d]pyridazinone derivatives in neuroinflammation induced by preincubation with lipopolysaccharide or coculturing with microglia-like cells. Biomedicine & Pharmacotherapy 141, pages 111878.
Crossref
Crossref
Tien-Wei Yu, Hsien-Yuan Lane & Chieh-Hsin Lin. (2021) Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review. International Journal of Molecular Sciences 22:15, pages 8208.
Crossref
Crossref
Qiu-yue Xiao, Tian-yuan Ye, Xiao-long Wang, Lu Han, Tong-xing Wang, Dong-mei Qi, Xiao-rui Cheng & Sheng-qi Wang. (2021) A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease. Experimental Gerontology 149, pages 111336.
Crossref
Crossref
Milan Stoiljkovic, Tamas L. Horvath & Mihály Hajós. (2021) Therapy for Alzheimer’s disease: Missing targets and functional markers?. Ageing Research Reviews 68, pages 101318.
Crossref
Crossref
Carmen Laura Sayas & Jesús Ávila. (2021) GSK-3 and Tau: A Key Duet in Alzheimer’s Disease. Cells 10:4, pages 721.
Crossref
Crossref
Ayush Singh, Dyron Allen, Anna Fracassi, Batbayar Tumurbaatar, Chandramouli Natarajan, Pietro Scaduto, Randy Woltjer, Rakez Kayed, Agenor Limon, Balaji Krishnan & Giulio Taglialatela. (2020) Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Journal of Alzheimer's Disease 78:4, pages 1661-1678.
Crossref
Crossref
Patricia Chastagner, Frida Loria, Jessica Y Vargas, Josh Tois, Marc I Diamond, George Okafo, Christel Brou & Chiara Zurzolo. (2020) Fate and propagation of endogenously formed Tau aggregates in neuronal cells. EMBO Molecular Medicine 12:12.
Crossref
Crossref
Antonio Dominguez-Meijide, Eftychia Vasili & Tiago Fleming Outeiro. (2020) Pharmacological Modulators of Tau Aggregation and Spreading. Brain Sciences 10:11, pages 858.
Crossref
Crossref
Steven S. Plotkin & Neil R. Cashman. (2020) Passive immunotherapies targeting Aβ and tau in Alzheimer's disease. Neurobiology of Disease 144, pages 105010.
Crossref
Crossref
Chiara Pedicone, Sandra Fernandes, Otto M. Dungan, Shawn M. Dormann, Dennis R. Viernes, Arijit A. Adhikari, Lydia B. Choi, Ebbing P. De Jong, John D. Chisholm & William G. Kerr. (2020) Pan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis. Journal of Cell Science 133:5.
Crossref
Crossref
Alex Crowe, Mark J. Henderson, Johnathon Anderson, Steven A. Titus, Alexey Zakharov, Anton Simeonov, Arjan Buist, Charlotte Delay, Diederik Moechars, John Q. Trojanowski, Virginia M.-Y. Lee & Kurt R. Brunden. (2020) Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays. Journal of Biological Chemistry 295:12, pages 4001-4013.
Crossref
Crossref
Alice Bittar, Nemil Bhatt & Rakez Kayed. (2020) Advances and considerations in AD tau-targeted immunotherapy. Neurobiology of Disease 134, pages 104707.
Crossref
Crossref
Pi-Shan Sung, Po-Yu Lin, Chi-Hung Liu, Hui-Chen Su & Kuen-Jer Tsai. (2020) Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches. International Journal of Molecular Sciences 21:3, pages 701.
Crossref
Crossref
Arunachalam Muthuraman, Muthusamy Ramesh & Thiagarajan Venkata Rathina Kumar. 2020. Principles of Neurochemistry. Principles of Neurochemistry
101
136
.
Diptaman Chatterjee & Jeffrey H. Kordower. (2019) Immunotherapy in Parkinson’s disease: Current status and future directions. Neurobiology of Disease 132, pages 104587.
Crossref
Crossref
Marcella Catania, Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini & Giuseppe Di Fede. (2019) Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Caixiu Lin, Shuai Zhao, Yueli Zhu, Ziqi Fan, Jing Wang, Baorong Zhang & Yanxing Chen. (2019) Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease. Computational and Structural Biotechnology Journal 17, pages 1309-1317.
Crossref
Crossref